Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- 1 Commonwealth Lane
- Most recent report
- 6-K, filed Oct 13, 2026
- Filings on record
- 131 filings
- On EDGAR
- CIK 1873093
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 45
- 6-K Report a foreign issuer made public elsewhere Oct 13, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 30, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 23, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 3, 2026
- 6-K Report a foreign issuer made public elsewhere May 15, 2026
- 6-K Report a foreign issuer made public elsewhere May 11, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 14, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 31, 2026
Prospectuses and Registrations 7
- 424B5 Prospectus supplement for an offering Aug 18, 2025
- F-3 Jun 13, 2025
- S-8 Registration statement for an employee plan Jan 6, 2025
- 424B4 Final prospectus for an offering Apr 17, 2023
- FWP Free writing prospectus Mar 31, 2023
- FWP Free writing prospectus Feb 27, 2023
- F-1 Registration statement, foreign issuer Nov 18, 2022
Ownership 8 of 41
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 16, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 13, 2026
- 144 Notice of a proposed sale of restricted stock Aug 11, 2026
- 4/A Insider reported a trade, amended Jul 24, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 24, 2026
- 4 Insider reported a trade Jul 24, 2026
- 4 Insider reported a trade Jun 15, 2026
- 3 Insider reported their initial holding May 26, 2026
Other 8 of 38
- EFFECT Notice that a registration became effective Jun 23, 2025
- CORRESP Reply to SEC staff Jun 20, 2025
- UPLOAD Comment letter from SEC staff Jun 18, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Jun 24, 2024
- 6-K/A Report a foreign issuer made public elsewhere, amended Apr 25, 2024
- CERT Exchange certified a listing Apr 14, 2023
- SEC STAFF LETTER Mar 31, 2023
- EFFECT Notice that a registration became effective Mar 31, 2023
Everything here comes from CytoMed Therapeutics Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.